TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Black Lung Disease Market, by Type
6.1 Introduction
6.2 Simple Coal Workerโs Pneumoconiosis
Market Estimates & Forecast, 2023 โ 2030
6.3 Complicated Coal Workerโs Pneumoconiosis
Market Estimates & Forecast, 2023 โ 2030
6.4 Others
Chapter 7. Global Black Lung Disease Market, by Diagnosis
7.1 Introduction
7.2 Biopsy
Market Estimates & Forecast, 2023 โ 2030
7.3 Imaging
Market Estimates & Forecast, 2023 โ 2030
7.3.1 CT
7.3.2 X-ray
7.3.3 Others
7.4 Full Blood Count
Market Estimates & Forecast, 2023 โ 2030
7.5 Pulmonary/Lung Function Tests
Market Estimates & Forecast, 2023 โ 2030
7.6 Physical Examination
Market Estimates & Forecast, 2023 โ 2030
7.7 Others
Chapter 8. Global Black Lung Disease Market, by Treatment
8.1 Introduction
8.2 Oxygen Therapy
Market Estimates & Forecast, 2023 โ 2030
8.3 Bronchodilators
Market Estimates & Forecast, 2023 โ 2030
8.4 Lung Transplant
Market Estimates & Forecast, 2023 โ 2030
8.5 Stem Cell Therapy
Market Estimates & Forecast, 2023 โ 2030
8.6 Others
Chapter 9. Global Black Lung Disease Market, by End User
9.1 Introduction
9.2 Hospitals & Clinics
Market Estimates & Forecast, 2023 โ 2030
9.3 Research Organizations & Academic Institutes
Market Estimates & Forecast, 2023 โ 2030
9.4 Diagnostic Centers & Labs
Market Estimates & Forecast, 2023 โ 2030
9.5 Others
Chapter 10. Global Black Lung Disease Market, by Region
10.1 Introduction
10.2 America
10.2.1 North America
10.2.1.1 U.S.
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 U.K.
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 The Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of the Middle East & Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
11.3.1 Key Developments
Chapter 12 Company Profiles
12.1 Boehringer Ingelheim International GmbH
12.1.1 Company Overview
12.1.2 Type Overview
12.1.3 Financials
12.2.4 Key Developments
12.1.5 SWOT Analysis
12.2 GlaxoSmithKline plc
12.2.1 Company Overview
12.2.2 Type Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Novartis AG
12.3.1 Company Overview
12.3.2 Type Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Teva Pharmaceutical Industries Ltd.
12.4.1 Company Overview
12.4.2 Type/Business Segment Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 AstraZeneca
12.5.1 Company Overview
12.5.2 Type Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Koninklijke Philips N.V.
12.6.1 Company Overview
12.6.2 Type Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 GENERAL ELECTRIC
12.7.1 Overview
12.7.2 Type Overview
12.7.3 Financials
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 Siemens AG
12.8.1 Overview
12.8.2 Type Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 TOSHIBA CORPORATION
12.9.1 Overview
12.9.2 Type Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
12.10 Medtronic
12.10.1 Overview
12.10.2 Type Overview
12.10.3 Financials
12.10.4 Key Developments
12.10.5 SWOT Analysis
12.11 Others
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOโs View Point
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Prediction of Black Lung Disease Market
Chapter 14 Appendix
LIST OF TABLES
Table 1 Black Lung Disease Industry Synopsis, 2023 โ 2030
Table 2 Global Black Lung Disease Market Estimates and Forecast, 2023 โ 2030, (USD Million)
Table 3 Global Black Lung Disease Market by Region, 2023 โ 2030, (USD Million)
Table 4 Global Black Lung Disease Market by Type, 2023 โ 2030, (USD Million)
Table 5 Global Black Lung Disease Market by Diagnosis, 2023 โ 2030, (USD Million)
Table 6 Global Black Lung Disease Market by Treatment, 2023 โ 2030, (USD Million)
Table 7 Global Black Lung Disease Market by End User, 2023 โ 2030, (USD Million
Table 8 North America Black Lung Disease Market by Type, 2023 โ 2030, (USD Million)
Table 9 North America Black Lung Disease by Diagnosis, 2023 โ 2030, (USD Million)
Table 10 North America Black Lung Disease by Treatment, 2023 โ 2030, (USD Million)
Table 11 North America Black Lung Disease by End User, 2023 โ 2030, (USD Million)
Table 12 U.S. Black Lung Disease Market by Type, 2023 โ 2030, (USD Million)
Table 13 U.S. Black Lung Disease Market by Diagnosis, 2023 โ 2030, (USD Million)
Table 14 U.S. Black Lung Disease Market by Treatment, 2023 โ 2030, (USD Million)
Table 15 U.S. Black Lung Disease Market by End User, 2023 โ 2030, (USD Million)
Table 16 Canada Black Lung Disease Market by Type, 2023 โ 2030, (USD Million)
Table 17 Canada Black Lung Disease Market by Diagnosis, 2023 โ 2030, (USD Million)
Table 18 Canada Black Lung Disease Market by Treatment, 2023 โ 2030, (USD Million)
Table 19 Canada Black Lung Disease Market by End User, 2023 โ 2030, (USD Million)
Table 20 South America Black Lung Disease Market by Type, 2023 โ 2030, (USD Million)
Table 21 South America Black Lung Disease Market by Diagnosis, 2023 โ 2030, (USD Million)
Table 22 South America Black Lung Disease Market by Treatment, 2023 โ 2030, (USD Million)
Table 23 South America Black Lung Disease Market by End User, 2023 โ 2030, (USD Million)
Table 24 Europe Black Lung Disease Market by Type, 2023 โ 2030, (USD Million)
Table 25 Europe Black Lung Disease Market by Diagnosis, 2023 โ 2030, (USD Million)
Table 26 Europe Black Lung Disease Market by Treatment, 2023 โ 2030, (USD Million)
Table 27 Europe Black Lung Disease Market by End User, 2023 โ 2030, (USD Million)
Table 28 Western Europe Black Lung Disease Market by Type, 2023 โ 2030, (USD Million)
Table 29 Western Europe Black Lung Disease Market by Diagnosis, 2023 โ 2030, (USD Million)
Table 30 Western Europe Black Lung Disease Market by Treatment, 2023 โ 2030, (USD Million)
Table 31 Western Europe Black Lung Disease Market by End User, 2023 โ 2030, (USD Million)
Table 32 Eastern Europe Black Lung Disease Market by Type, 2023 โ 2030, (USD Million)
Table 33 Eastern Europe Black Lung Disease Market by Diagnosis, 2023 โ 2030, (USD Million)
Table 34 Eastern Europe Black Lung Disease Market by Treatment, 2023 โ 2030, (USD Million)
Table 35 Eastern Europe Black Lung Disease Market by End User, 2023 โ 2030, (USD Million)
Table 36 Asia Pacific Black Lung Disease Market by Type, 2023 โ 2030, (USD Million)
Table 37 Asia Pacific Black Lung Disease Market by Diagnosis, 2023 โ 2030, (USD Million)
Table 38 Asia Pacific Black Lung Disease Market by Treatment, 2023 โ 2030, (USD Million)
Table 39 Asia Pacific Black Lung Disease Market by End User, 2023 โ 2030, (USD Million)
Table 40 The Middle East & Africa Black Lung Disease Market by Type, 2023 โ 2030, (USD Million)
Table 41 The Middle East & Africa Black Lung Disease Market by Diagnosis, 2023 โ 2030, (USD Million)
Table 42 The Middle East & Africa Black Lung Disease Market by Treatment, 2023 โ 2030, (USD Million)
Table 43 The Middle East & Africa Black Lung Disease Market by End User, 2023 โ 2030, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Black Lung Disease Market
Figure 3 Market Dynamics for Global Black Lung Disease Market
Figure 4 Global Black Lung Disease Market Share, by Type 2023
Figure 5 Global Black Lung Disease Market Share, by Diagnosis 2023
Figure 6 Global Black Lung Disease Market Share, by Treatment, 2023
Figure 7 Global Black Lung Disease Market Share, by End User, 2023
Figure 8 Global Black Lung Disease Market Share, by Region, 2023
Figure 9 North America Black Lung Disease Market Share, by Country, 2023
Figure 10 Europe Black Lung Disease Market Share, by Country, 2023
Figure 11 Asia Pacific Black Lung Disease Market Share, by Country, 2023
Figure 12 The Middle East & Africa Black Lung Disease Market Share, by Country, 2023
Figure 13 Global Black Lung Disease Market: Company Share Analysis, 2023 (%)
Figure 14 Boehringer Ingelheim International GmbH: Key Financials
Figure 15 Boehringer Ingelheim International GmbH: Segmental Revenue
Figure 16 Boehringer Ingelheim International GmbH: Geographical Revenue
Figure 17 GlaxoSmithKline plc: Key Financials
Figure 18 GlaxoSmithKline plc: Segmental Revenue
Figure 19 GlaxoSmithKline plc: Geographical Revenue
Figure 20 Novartis AG: Key Financials
Figure 21 Novartis AG: Segmental Revenue
Figure 22 Novartis AG: Geographical Revenue
Figure 23 Teva Pharmaceutical Industries Ltd.: Key Financials
Figure 24 Teva Pharmaceutical Industries Ltd.: Segmental Revenue
Figure 25 Teva Pharmaceutical Industries Ltd.: Geographical Revenue
Figure 26 AstraZeneca: Key Financials
Figure 27 AstraZeneca: Segmental Revenue
Figure 28 AstraZeneca: Geographical Revenue
Figure 29 Koninklijke Philips N.V.: Key Financials
Figure 30 Koninklijke Philips N.V.: Segmental Revenue
Figure 31 Koninklijke Philips N.V.: Geographical Revenue
Figure 32 GENERAL ELECTRIC: Key Financials
Figure 33 GENERAL ELECTRIC: Segmental Revenue
Figure 34 GENERAL ELECTRIC: Geographical Revenue
Figure 35 Siemens AG: Key Financials
Figure 36 Siemens AG: Segmental Revenue
Figure 37 Siemens AG: Geographical Revenue
Figure 38 TOSHIBA CORPORATION: Key Financials
Figure 39 TOSHIBA CORPORATION: Segmental Revenue
Figure 40 TOSHIBA CORPORATION: Geographical Revenue
Figure 41 Medtronic: Key Financials
Figure 42 Medtronic: Segmental Revenue
Figure 43 Medtronic: Geographical Revenue